Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Design Therapeutics (DSGN) Non Operating Income (2020 - 2026)

Design Therapeutics' Non Operating Income history spans 2 years, with the latest figure at $62000.0 for Q4 2021.

  • On a quarterly basis, Non Operating Income rose 933.33% to $62000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $298000.0, a 496.0% increase, with the full-year FY2025 number at $9.7 million, up 4.57% from a year prior.
  • Non Operating Income hit $62000.0 in Q4 2021 for Design Therapeutics, up from $19000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for DSGN hit a ceiling of $166000.0 in Q1 2021 and a floor of -$40000.0 in Q1 2020.